2013
DOI: 10.1021/om301157z
|View full text |Cite
|
Sign up to set email alerts
|

1H-1,2,3-Triazole-Tethered Isatin–Ferrocene and Isatin–Ferrocenylchalcone Conjugates: Synthesis and in Vitro Antitubercular Evaluation

Abstract: A Cu-mediated azide−alkyne cycloaddition protocol has been employed for the synthesis of 16 different triazoles to probe the antitubercular structure−activity relationships within the isatin−ferrocene− triazole conjugate family. The antitubercular evaluation studies revealed a marked improvement in activity with the introduction of ferrocene nucleus among precursors N-alkylazido isatins with a prefernce for halogen (F, Cl) substituent at C-5 position of isatin as well as propyl chain length as a spacer. The in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
37
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 91 publications
(37 citation statements)
references
References 56 publications
0
37
0
Order By: Relevance
“…Recent disclosure from our group has shown the synthesis of 1 H ‐1,2,3‐triazole‐tethered β‐lactam‐ferrocene and β‐lactam‐ferrocenylchalcone hybrids along with the evaluation of their antitubercular activities [20]. The methodology was further developed toward the synthesis of 1 H ‐1,2,3‐triazole‐linked isatin‐ferrocene and isatin‐ferrocenylchalcone conjugates with a further extension to include spiro‐isatin in these molecular conjugates along with their evaluation against M. tuberculosis [21]. Continuing with our efforts, the present article describes the synthesis of uracil‐ferrocene and uracil‐ferrocenylchalcone conjugates, linked via 1 H ‐1,2,3‐triazole functionality (as shown in Figure ), along with their antitubercular evaluation.…”
Section: Introductionmentioning
confidence: 99%
“…Recent disclosure from our group has shown the synthesis of 1 H ‐1,2,3‐triazole‐tethered β‐lactam‐ferrocene and β‐lactam‐ferrocenylchalcone hybrids along with the evaluation of their antitubercular activities [20]. The methodology was further developed toward the synthesis of 1 H ‐1,2,3‐triazole‐linked isatin‐ferrocene and isatin‐ferrocenylchalcone conjugates with a further extension to include spiro‐isatin in these molecular conjugates along with their evaluation against M. tuberculosis [21]. Continuing with our efforts, the present article describes the synthesis of uracil‐ferrocene and uracil‐ferrocenylchalcone conjugates, linked via 1 H ‐1,2,3‐triazole functionality (as shown in Figure ), along with their antitubercular evaluation.…”
Section: Introductionmentioning
confidence: 99%
“…Insertion of of triazole moiety into the N ‐n‐hexyl‐ N ‐phenylanilinochalcone dendritic structure would enhance the biological properties . The synthetic pathway leading to N ‐n‐hexyl‐ N ‐phenylanilinochalcone dendrimers incorporating triazole moiety is shown in Scheme .…”
Section: Resultsmentioning
confidence: 99%
“…Continuing with our efforts in the synthesis of novel molecular conjugates with biological potential (Raj et al, 2013c;Raj et al, 2013a;Nisha et al, 2013;Kumar et al, 2013;Kumar et al 2012), we recently discussed the synthesis of 1H-1,2,3-triazole-tethered b-lactam-isatin conjugates and their in vitro evaluation against T. vaginalis Raj et al, 2013b). Most of the synthesized compounds exhibited 100 % growth inhibition at 100 lM with the most potent and non-cytotoxic compound (Fig.…”
Section: Introductionmentioning
confidence: 92%